|
Other articles:
|
www.benzinga.com/. /orthovita-announces-presentation-of-cortoss-24- month-pivotal-study-resuCachedOct 6, 2010 . . Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,” at . In
www.highbeam.com/doc/1G1-202126840.htmlJun 15, 2009 . And Orthovita Inc. (Malvern PA) was cleared to sell its Cortoss bone
www.aboutstryker.com/orthobiologics/files/CortossIDEStudy.pdfCachedSimilarthe direct apposition to bone over time.4 In support of its FDA clearance, Cortoss
www.asaabstracts.com/strands/asaabstracts/abstract.htm?year=2007. Using Cortoss To Treat Vertebral Compression Fractures with Kyphoplasty and .
www.businesswire.com/. /Orthovita-Receives-FDA-Clearance-CORTOSS™- Bone-AugmentationCachedSimilarJun 8, 2009 . “CORTOSS is the first FDA-cleared alternative in this product category. Our
www.annualreports.com/HostedData/AnnualReports/. /vita2009.pdfCachedMar 16, 2010 . our novel, synthetic bone augmentation material, received FDA clearance for the
www.raganvirtualworkshops.com/1613.php4Sep 16, 2008 . Orthovita, Inc. (NASDAQ:VITA), a spine and orthopedic biosurgery company,
www.healio.com/. /pain-disability-decrease-after-augmenting-vertebral- fractures-with-bioceramic-fillerCachedSimilarCortoss is not FDA-approved for use in the United States. . Cortoss sets at about
www.advfn.com/news_Orthovita-Announces-Publication-of-24-Month-Data- f_44436409.htmlCachedSep 20, 2010 . The article presents the clinical data from two FDA-approved investigational .
www.streetinsider.com/FDA/. FDA. CORTOSS/4714206.htmlCachedJun 8, 2009 . Orthovita, Inc. (NASDAQ: VITA) announced that it received 510(k) clearance from
www.biospace.com/News/1-reports-cortoss. data-to. /19158320CachedOct 19, 2005 . . Multi-Center Pilot IDE Study on the Use of Cortoss in Vertebroplasty . Such As
FIGURE 15-2 Comparison of radiopacity of Cortoss to other cements such as .
www.rttnews.com/. /orthovita-gets-fda-clearance-to-market-cortoss-bone- augmentation-material.aspxCachedJun 8, 2009 . Orthovita Inc. (VITA) said that it has received 510(k) clearance from the FDA to
spineblogger.blogspot.com/. /playoffs-are-upon-us-is-orthovita-set.htmlCachedSep 24, 2010 . The results of this study were the basis of Cortoss' clearance by the FDA. As we
theassr.org/. /cortoplasty-treatment-of-vertebral-compression-fractures-with- cortoss-for-vertebral-augmentation-preliminary-results-of-prospecti. CachedCortoplasty- Treatment of Vertebral Compression Fractures with Cortoss for
strykerivs.com/products/cortossCachedSimilarCortoss is an injectable, non-resorbable composite consisting of crosslinking . ^
www.4-traders.com/. /Orthovita-Inc--Orthovita-Announces-Podium- Presentation-of-CORTOSSR-for-the-Treatment-of-Vertebral-37549. CachedJun 11, 2007 . Treatment of Osteoporotic VCF with CORTOSS ®: Preliminary Results .
connection.ebscohost.com/. /orthovitas-cortoss-synthetic-bone-filler-more- effectiveFocuses on clinical studies which examined the efficacy of CORTOSS Synthetic
www.newsrx.com/newsletters/. FDA/. /0517200633331DC.htmlCachedMay 17, 2006 . Orthovita, Inc. (VITA), a developer of orthopedic biomaterials, announced that the
www.bizjournals.com/philadelphia/stories/2009/06/08/daily4.htmlCachedJun 8, 2009 . Orthovita Inc. said Monday that the Food and Drug Administration has given it
www.orthospinenews.com/orthovita-receives-fda-clearance-for-cortoss™- bone-augmentation-material-in-treatment-of-vertebral-compression-. CachedJun 8, 2009 . Orthovita Receives FDA Clearance for CORTOSS™ Bone Augmentation Material
www.sec.gov/Archives/edgar/data/913756/. /dex991.htmCachedPivotal Clinical Study for the Use of CORTOSS® in the Treatment. of Vertebral
https://www.wordnik.com/words/CortossCachedThe Cortoss is a manufacturing ability in scale for commercial scale. . Orthovita
www.ncbi.nlm.nih.gov/pubmed/21738093SimilarApr 1, 2012 . A prospective randomized FDA-IDE trial comparing Cortoss with PMMA for
www.cxvascular.com/. /fda-ide-study-finds-vertebroplasty-with-cortoss-has- better-patient-outcomesCachedFeb 7, 2011 . Hyun W Bae presented long-term functional results observed in a multicentre
caps.fool.com/Pitch/VITA.DL/. /this-company-is-steering-corto.aspxCachedMay 28, 2008 . This company is steering Cortoss toward FDA approval. Cortoss is a cement that
www.bloomberg.com/apps/news?pid=newsarchive&sid. CachedOrthovita Receives FDA Clearance for CORTOSS™ Bone Augmentation Material
www.accessdata.fda.gov/cdrh_docs/pdf8/K080108.pdfCachedSimilarMay 28, 2009 . CORTOSS. 510(k) Notification. Orthovita, Inc. 510(k) SUMMARY. CORTOSS. ®.
www.medicaldeviceguru.com/showthread.php?t=3754Orthovita, Inc. (NASDAQ:VITA), a spine and orthopedic biosurgery company,
technews.tmcnet.com/business-video/news/2010/07/19/4908135.htmJul 19, 2010 . . Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial," at .
www.thefreelibrary.com/FDA+Approves+New+Clinical+Trial+Design+for+ the+Study+of+CORTOSS+in. -a0121122562CachedFree Online Library: FDA Approves New Clinical Trial Design for the Study of
www.azom.com/article.aspx?ArticleID=1967CachedMay 6, 2003 . Orthovita have received US FDA approval to run a second clinical trial involving
www.researchgate.net/. /51475869_A_prospective_randomized_FDA-IDE_ trial_comparing_Cortoss_with_PMMA_for_vertebroplasty_a_comparative. Publication » A prospective randomized FDA-IDE trial comparing Cortoss with
www.pharmiweb.com/pressreleases/pressrel.asp?. CachedSep 20, 2010 . The article presents the clinical data from two FDA-approved . feasibility and
helpingbacks.com/conditions/spinal-fracture/treatment/injectablesCachedSimilarResults demonstrate that PMMA and Cortoss are both effective in alleviating . ^
www.mdlinx.com/endocrinology/print.cfm/4001347/vertebroplastyCachedPrint Article: A Prospective Randomized FDA-IDE Trial Comparing Cortoss With
www.pharmacychoice.com/news/article.cfm?Article_ID=607955Jul 19, 2010 . . Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,? . (IDE)
www.news-medical.net/. /Orthovitas-Cortoss-Bone-Augmentation-study- results-to-be-presented-at-NASS-Annual-Meeting.aspxCachedOct 6, 2010 . . Prospective, Randomized, Controlled FDA-IDE Vertebroplasty Trial,at the 25th
New investigation results, 'Clinical experience using Cortoss for treating vertebral
www.healthpointcapital.com/. /06/. /cortoss_receives_fda_clearance/CachedJun 9, 2009 . Orthovita has received 510(k) clearance to market Cortoss Bone Augmentation
www.biomedreports.com/. /orthovita-receives-fda-clearance-for-cortoss- bone-augmentation-material.htmlCachedJun 8, 2009 . Orthovita, Inc. (NASDAQ:VITA), a leading orthobiologics and biosurgery company
www.wikinvest.com/stock/. /Cortoss_Bone_Augmentation_MaterialCachedSimilarWe have sold approximately 12,000 units of CORTOSS through December 31,
www.ajnr.org/content/early/2012/06/28/ajnr.A3156.full.pdfJun 28, 2012 . fractures, Cortoss and PMMA, were compared in a prospective, randomized .
www.docguide.com//%252Fnode/1252935CachedSTUDY DESIGN.: Forty patients were enrolled in 2 FDA-approved pilot
www.adrsupport.org/. /f51/vertebroplasy-material-cortoss-fda-8698/CachedThe material is CORTOSS. While this FDA study is for bone fractures you can see
media.corporate-ir.net/media_files/NSD/VITA/. /vita_ar00.pdfCachedNov 9, 2001 . CORTOSS™ and RHAKOSS™ are under development and are not . resulted in
www.euroinvestor.com/news/. fda. cortossr. /9700327CachedJan 15, 2008 . Orthovita Submits 510(k) Application to FDA for the Use of CORTOSS(R) Bone
www.rontis.gr/wp-content/. /12/Cortoss-Bone-Augmentation-Material.pdfCortoss Bone Augmentation Material is an injectable, bioactive* composite . . A
seekingalpha.com/article/106811-orthovita-showing-some-spineCachedNov 19, 2008 . VITA has a medical device under review for approval with the FDA. Cortoss is a
www.thestreet.com/. /orthovita-announces-publication-of-24-month-data- from-cortoss-clinical-pilot-studies-in-vertebroplasty-and-kyphoplasty.htmlSep 20, 2010 . The article presents the clinical data from two FDA-approved investigational .
Sitemap
|